The survival rates of breast cancer patients are improving over the last decade, with an overall five-year survival rate of 72% for newly diagnosed cases in 2009 compared with 62% in 1998. This change is mainly driven by reductions in mortality among women younger than 50 years old.
In a recent study, the data suggests that hormonal factors play the major role in development of breast cancers. It seems that both genetic and environmental factors contribute to development of breast cancers. Results from a recent clinical trial also show that the causative factors of breast cancers are changing due to modern environment and lifestyle changes. We believe that our work will help to develop new treatments of breast cancers.
Results from a recent paper give a more complete picture of how fast breast cancer spreads compared with what was found using only the data on distant metastases. For patients with localized disease, there is considerable variation in the rate of tumor progression between individuals.
Results from a recent clinical trial suggests that among women born in Australia, the lifetime risk of developing breast cancer is 5.9%. There were no differences between men and women in terms of breast cancer risk.
There are numerous research findings that may pave the way for additional advances in the treatment of breast cancer. This article focuses solely on new advancements in the field of radiation therapy and chemotherapy.